V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10315465 | 10072259 | 1.78 | 68 | null | 2021-10-19 | 2021-10-22 | null | 02 | null | RITUXIMAB + VENETOCLAX | 100888441 |
| 10318122 | 10072262 | 1.51 | 79 | null | 2016-10-06 | 2016-10-11 | null | 02 | null | BORTEZOMIB + DARATUMUMAB | 101315589 |
| 10318159 | 10072263 | null | null | null | 2019-07-04 | 2019-07-18 | null | 02 | null | RITUXIMAB + VENETOCLAX | 100405811 |
| 10318813 | 10072264 | 1.84 | 70.2 | null | null | 2020-08-20 | null | 02 | null | CARBOPLATIN + ETOPOSIDE | 100441879 |
| 10319262 | 10072267 | 1.49 | 73.5 | Neo-adjuvant (N) | 2021-08-06 | 2021-08-19 | null | 02 | N | POMALIDOMIDE | 101500619 |
| 10320532 | 10072268 | 1.59 | 65 | Palliative (P) | null | 2018-06-04 | null | 02 | N | CARBOPLATIN + ETOPOSIDE | 101819757 |
| 10321661 | 10072270 | 1.83 | 76.3 | null | 2022-01-02 | 2022-03-05 | null | 02 | null | RADIUM 223 | 100687840 |
| 10323152 | 10072271 | 1.84 | 90.7 | null | 2019-02-28 | 2019-02-28 | Bortezomib + Daratumumab | 02 | N | BORTEZOMIB + DARATUMUMAB | 100164694 |
| 10325540 | 10072274 | 1.73 | 110 | null | 2020-01-25 | 2020-01-25 | null | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100900869 |
| 10326909 | 10072276 | 1.76 | 81.4 | Palliative (P) | 2019-07-22 | 2019-07-22 | null | 02 | N | ATEZOLIZUMAB | 100048468 |
| 10329035 | 10072278 | 1.75 | 61.6 | null | 2019-12-11 | 2020-01-01 | null | 02 | null | ATEZOLIZUMAB | 100904689 |
| 10329739 | 10072280 | 1.64 | 77 | null | 2022-04-29 | 2022-04-29 | null | 02 | null | BACILLUS CALMETTE-GUERIN | 100954058 |
| 10330398 | 10072282 | 1.8 | null | null | 2021-12-20 | 2022-01-06 | null | 02 | null | BORTEZOMIB + DARATUMUMAB | 100291968 |
| 10330979 | 10072283 | 1.87 | 0 | null | 2020-11-26 | 2020-12-16 | null | 02 | null | POMALIDOMIDE | 100452643 |
| 10331403 | 10072284 | 1.72 | 84 | Palliative (P) | 2021-02-19 | 2021-02-24 | null | 02 | N | IXAZOMIB + LENALIDOMIDE | 100152013 |
| 10332384 | 10072286 | 1.56 | 61.05 | null | 2021-05-04 | 2021-05-04 | null | 02 | null | TEMOZOLOMIDE | 100402818 |
| 10333576 | 10072287 | 1.68 | 103.6 | Palliative (P) | 2016-05-27 | 2018-12-28 | null | 02 | N | CARBOPLATIN + PEMETREXED | 101130252 |
| 10334459 | 10072288 | 1.53 | 44.7 | null | 2020-11-20 | 2020-11-20 | null | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100347002 |
| 10334840 | 10072289 | null | 124 | 03 | 2018-04-28 | 2018-05-08 | null | 02 | N | ATEZOLIZUMAB | 101617369 |
| 10335799 | 10072291 | 1.71 | 70.35 | null | 2022-02-24 | 2022-03-10 | null | 02 | null | CARBOPLATIN + ETOPOSIDE | 100110642 |
| 10335969 | 10072292 | 1.67 | 108 | Palliative (P) | 2021-02-07 | 2021-02-19 | POMALIDOMIDE | 02 | N | POMALIDOMIDE | 101325059 |
| 10337202 | 10072294 | null | null | null | 2018-03-03 | 2018-05-01 | Radium 223 | 02 | null | CARBOPLATIN + ETOPOSIDE | 100709955 |
| 10342041 | 10072296 | 0 | 75 | null | 2020-10-16 | 2020-10-27 | Gemcitabine + Methylprednisolone | 02 | null | GEMCITABINE | 100515927 |
| 10354581 | 10072299 | 1.69 | 76 | Palliative (P) | 2019-11-07 | 2019-11-14 | CAPECITABINE + IRINOTECAN | 02 | N | CISPLATIN | 100820369 |
| 10355560 | 10072300 | 1.62 | 82.15 | null | 2021-05-13 | 2022-04-28 | Bortezomib (weekly) | 02 | null | BORTEZOMIB | 101498072 |
| 10358907 | 10072302 | 1.6 | 0 | Neo-adjuvant (N) | 2021-04-07 | 2021-04-21 | Chlorambucil | 02 | null | CHLORAMBUCIL | 100331139 |
| 10359193 | 10072303 | 1.67 | 54 | Curative (C) | 2022-01-07 | 2022-02-25 | DABRAFENIB + TRAMETINIB | 02 | N | DABRAFENIB + TRAMETINIB | 100567201 |
| 10365670 | 10072308 | 1.59 | 57.5 | null | 2022-02-12 | 2022-02-15 | CHLORAMBUCIL + OBINUTUZUMAB | 01 | null | CHLORAMBUCIL + OBINUTUZUMAB | 101222193 |
| 10369028 | 10072310 | 1.66 | 75 | Palliative (P) | 2020-10-20 | 2020-10-25 | CHLORAMBUCIL + OBINUTUZUMAB | 02 | N | CHLORAMBUCIL + OBINUTUZUMAB | 100358720 |
| 10369153 | 10072311 | 1.74 | 98 | null | 2017-12-11 | 2018-06-22 | CISPLATIN + VINORELBINE | 02 | null | CISPLATIN + GEMCITABINE | 100332133 |
| 10369910 | 10072314 | 0 | 74 | Curative (C) | 2015-09-23 | 2017-03-12 | Cabazitaxel | 02 | N | CABAZITAXEL | 101524358 |
| 10371607 | 10072315 | 1.75 | 54.5 | null | null | null | Bortezomib (weekly) | 02 | null | BORTEZOMIB | 100704184 |
| 10371951 | 10072316 | 1.72 | 94 | null | 2020-02-15 | 2020-03-07 | Methotrexate intrathecal | 02 | null | METHOTREXATE | 100237364 |
| 10372696 | 10072317 | 1.62 | 50 | null | 2019-02-10 | 2019-03-22 | Chlorambucil | 02 | null | CHLORAMBUCIL | 100609012 |
| 10374243 | 10072318 | 1.66 | 84.4 | Palliative (P) | 2020-01-26 | 2020-02-09 | Gemcitabine weekly | 02 | N | GEMCITABINE | 100520147 |
| 10374886 | 10072319 | 1.83 | null | Palliative (P) | 2021-09-05 | 2021-11-09 | BENDAMUSTINE + POLATUZUMAB VEDOTIN + RITUXIMAB | 02 | N | CAPECITABINE + IRINOTECAN | 101053096 |
| 10374966 | 10072320 | 1.62 | 84.6 | Palliative (P) | 2022-03-03 | 2022-05-24 | BORTEZOMIB + THALIDOMIDE | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101219231 |
| 10378276 | 10072324 | 1.56 | 107.9 | Palliative (P) | 2020-09-26 | 2020-11-30 | CABOZANTINIB | 02 | N | FLUOROURACIL | 100452186 |
| 10380513 | 10072328 | 1.86 | 57.8 | Palliative (P) | 2014-09-24 | 2017-03-08 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | NIRAPARIB | 101129962 |
| 10381113 | 10072329 | 1.71 | 77 | Curative (C) | 2018-10-29 | 2018-11-15 | PERTUZUMAB + TRASTUZUMAB | 02 | N | CABOZANTINIB | 101216699 |
| 10383158 | 10072333 | 1.84 | 44.5 | Palliative (P) | 2020-04-06 | 2020-05-04 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | BUSULFAN | 100700369 |
| 10383819 | 10072335 | 1.58 | 74 | Neo-adjuvant (N) | 2019-07-02 | 2020-10-05 | Cisplatin + Vinorelbine (IV) | 02 | N | CYCLOPHOSPHAMIDE + THALIDOMIDE | 100441465 |
| 10384319 | 10072337 | 1.74 | 91.75 | null | 2019-12-16 | 2020-01-28 | Palbociclib | 02 | null | PALBOCICLIB | 100176167 |
| 10385774 | 10072339 | 1.83 | null | null | 2020-06-16 | 2021-10-27 | CYCLOPHOSPHAMIDE | 02 | null | CYCLOPHOSPHAMIDE | 101162058 |
| 10386123 | 10072340 | 1.86 | 118 | null | null | 2018-06-12 | CISPLATIN + VINORELBINE | 02 | null | CISPLATIN + GEMCITABINE | 101063711 |
| 10386259 | 10072341 | 1.64 | 110.9 | Adjuvant (A) | 2020-01-15 | 2020-01-15 | Acalabrutinib | 02 | null | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | 100045841 |
| 10387807 | 10072342 | 1.8 | 61.7 | Palliative (P) | 2019-04-19 | 2019-04-25 | DABRAFENIB | 02 | N | BUSULFAN | 100494608 |
| 10388018 | 10072343 | 1.66 | 53.95 | Adjuvant (A) | 2018-04-11 | 2019-04-29 | Vinorelbine (oral) | 02 | N | VINORELBINE | 101054566 |
| 10388558 | 10072345 | 1.79 | 0 | Palliative (P) | null | 2019-06-02 | CVP R | 02 | N | VINORELBINE | 100157464 |
| 10389303 | 10072346 | 1.78 | null | Palliative (P) | 2019-04-20 | 2019-04-22 | CETUXIMAB + IRINOTECAN + MDG | 2 | N | CETUXIMAB | 101789811 |